Follow the IGC Pharma, Inc. stock price and the full insider trade history of the company, a listed issuer based in United States. Shares trade on the US market, under the supervision of SEC (Form 4). Market capitalisation: €26m. The latest transaction was filed on 6 April 2026 (Levée d'options). Among the most active insiders: Mukunda Ram. The full history is openly available.
25
Insider Decl.
n/a
Thresholds
€179,678
1 ops.
Buy Volume
n/a
n/a
Sell Volume
30Σ signal
Buys €179,678n/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 25,918 of 29,062 companies
22.8
score / 100
Value
10
Quality
36
FCF yld-17%
Earn yld-27%
EV/EBITDA·
ROE-83%
Gross mgn49%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
IGC Pharma, Inc. is a company focused on developing cannabinoid-based treatments for neurological and psychiatric disorders. It is listed on NASDAQ under the symbol IGC.